Catalysts for $NVO
43 tracked
Aug 5, 2026
earnings
NOVO NORDISK A S earnings
NOVO NORDISK A S
→
May 6, 2026
earnings
NOVO NORDISK A S earnings
NOVO NORDISK A S
→
Mar 26, 2026
approval
AWIQLI FLEXTOUCH (INSULIN ICODEC) — FDA approval
insulin icodec
→
Feb 27, 2026
approval
SOGROYA (SOMAPACITAN-BECO) — FDA approval
somatriptan albumin bound LA
→
Feb 27, 2026
approval
SOGROYA (SOMAPACITAN-BECO) — FDA approval
somatriptan albumin bound LA
→
Feb 27, 2026
approval
SOGROYA (SOMAPACITAN-BECO) — FDA approval
somatriptan albumin bound LA
→
Jan 7, 2026
recall
Novo Nordisk Inc. recall (Cls II)
NOVO NORDISK A S
→
Jan 7, 2026
recall
Novo Nordisk Inc. recall (Cls II)
NOVO NORDISK A S
→
Oct 14, 2025
approval
VICTOZA (LIRAGLUTIDE) — FDA approval
Saxenda
→
Jul 9, 2025
approval
SOGROYA (SOMAPACITAN-BECO) — FDA approval
somatriptan albumin bound LA
→
May 28, 2025
approval
VICTOZA (LIRAGLUTIDE) — FDA approval
Saxenda
→
Feb 12, 2025
approval
VICTOZA (LIRAGLUTIDE) — FDA approval
Saxenda
→
Jan 31, 2025
approval
SOGROYA (SOMAPACITAN-BECO) — FDA approval
somatriptan albumin bound LA
→
Nov 1, 2024
approval
VICTOZA (LIRAGLUTIDE) — FDA approval
Saxenda
→
Jul 5, 2023
approval
VICTOZA (LIRAGLUTIDE) — FDA approval
Saxenda
→
Apr 28, 2023
approval
SOGROYA (SOMAPACITAN-BECO) — FDA approval
somatriptan albumin bound LA
→
Jun 10, 2022
approval
VICTOZA (LIRAGLUTIDE) — FDA approval
Saxenda
→
Jun 10, 2022
approval
VICTOZA (LIRAGLUTIDE) — FDA approval
Saxenda
→
Oct 1, 2021
approval
SOGROYA (SOMAPACITAN-BECO) — FDA approval
somatriptan albumin bound LA
→
Oct 1, 2021
approval
SOGROYA (SOMAPACITAN-BECO) — FDA approval
somatriptan albumin bound LA
→
Nov 20, 2020
approval
VICTOZA (LIRAGLUTIDE) — FDA approval
Saxenda
→
Aug 28, 2020
approval
SOGROYA (SOMAPACITAN-BECO) — FDA approval
somatriptan albumin bound LA
→
Aug 5, 2020
approval
VICTOZA (LIRAGLUTIDE) — FDA approval
Saxenda
→
Jun 17, 2019
approval
VICTOZA (LIRAGLUTIDE) — FDA approval
Saxenda
→
Aug 25, 2017
approval
VICTOZA (LIRAGLUTIDE) — FDA approval
Saxenda
→
Jul 26, 2017
approval
VICTOZA (LIRAGLUTIDE) — FDA approval
Saxenda
→
Apr 25, 2017
approval
VICTOZA (LIRAGLUTIDE) — FDA approval
Saxenda
→
Sep 20, 2016
approval
VICTOZA (LIRAGLUTIDE) — FDA approval
Saxenda
→
Apr 22, 2016
approval
VICTOZA (LIRAGLUTIDE) — FDA approval
Saxenda
→
Jul 1, 2015
approval
VICTOZA (LIRAGLUTIDE) — FDA approval
Saxenda
→